Political Bargaining Intensifies In Final Days Before Vote On EMA’s New Home
Executive Summary
In the run-up to next Monday’s vote on the European Medicines Agency’s future home, political horse-trading and vote-swapping behind the scenes makes it difficult to predict which EU city will win the prized agency.
You may also be interested in...
EMA Discloses Staff’s Preferred Host Cities, Amid Fears Relocation Could Batter Its Budget
The EMA has published its analysis of the 19 bids to host the agency post-Brexit, which confirms reports that five cities – Amsterdam, Barcelona, Copenhagen, Milan and Vienna – would bring the best result in terms of retaining staff when it relocates. The agency has expressed concern that low retention rates could hit operations and result in lower fee income, requiring an injection of cash from the EU budget.
EMA Paints Nightmare Scenario Of EU System ‘Unraveling’ If Relocation Goes Wrong
The European Medicines Agency says it could lose more than 70% of its staff if it moves to one of the cities least favored by current employees. In the worst-case scenario, the EMA says it would be unable to operate and that the regulatory system would “unravel.”
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.